Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ProMetic Life Sciences -- Ignore unavailable to you. Want to Upgrade?

To: axial who wrote (172)	2/1/2018 3:08:35 PM
From: Cush	Respond to of 250

Thanks Jim. That is a very impressive and informative presentation. In a previous life-time, I sat through numerous presentations on Orthopaedic and Cardiac issues. This PLI presentation compares favourably with the best of those. Without going back to listen again, I believe the current market for IPF drugs is approximately $2 Billion, and those currently approved drugs are only being used in approximately 1/3 of potential patients, largely because of patient reluctance to deal with their side effects. We may have a drug here that is a more effective treatment with almost no side effects. You and I had some great stock choices in the past. This one has great potential. I wish we were in our 40's again because it is easy to imagine where this could go in the next 10 years. Take care, Cush